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Background: The rapid selection of pyrethroid resistance throughout sub-Saharan Africa is a serious threat to
malaria vector control. Chlorfenapyr is a pyrrole insecticide which shows no cross resistance to insecticide classes
normally used for vector control and is effective on mosquito nets under experimental hut conditions. Unlike
neurotoxic insecticides, chlorfenapyr owes its toxicity to disruption of metabolic pathways in mitochondria that
enable cellular respiration. A series of experiments explored whether standard World Health Organization (WHO)
guidelines for evaluation of long-lasting insecticidal nets, developed through testing of pyrethroid insecticides,
are suitable for evaluation of non-neurotoxic insecticides.
Methods: The efficacy of WHO recommended cone, cylinder and tunnel tests was compared for pyrethroids and
chlorfenapyr. To establish bioassay exposure times predictive of insecticide-treated net (ITN) efficacy in experimental
hut trials, standard three-minute bioassays of pyrethroid and chlorfenapyr ITNs were compared with longer
exposures. Mosquito behaviour and response to chlorfenapyr ITN in bioassays conducted at night were
compared to day and across a range of temperatures representative of highland and lowland transmission.
Results: Standard three-minute bioassay of chlorfenapyr produced extremely low levels of mortality compared to
pyrethroids. Thirty-minute day-time bioassay produced mortality closer to hut efficacy of chlorfenapyr ITN but still
fell short of the WHO threshold. Overnight tunnel test with chlorfenapyr produced 100% mortality and exceeded
the WHO threshold of 80%. The endogenous circadian activity rhythm of anophelines results in inactivity by day
and raised metabolism and flight activity by night. A model which explains improved toxicity of chlorfenapyr ITN
when tested at night, and during the day at higher ambient temperature, is that activation of chlorfenapyr and
disruption of respiratory pathways is enhanced when the insect is more metabolically and behaviourally active.
Conclusions: Testing according to current WHO guidelines is not suitable for certain types of non-neurotoxic
insecticide which, although highly effective in field trials, would be overlooked at the screening stage of evaluation
through bioassay. Testing methods must be tailored to the characteristics and mode of action of each insecticide
class. The WHO tunnel test on night-active anophelines is the most reliable bioassay for identifying the toxicity of
novel insecticides.
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Owing to the evolution and selection of high-level
resistance to pyrethroid insecticides in African malaria
vectors, there is an urgent need to develop novel
insecticides for mosquito net and indoor residual use
[1-3]. The need for safe, alternative insecticides is
particularly acute for mosquito nets [4], as no new
insecticides have been recommended by World Health
Organization (WHO) since pyrethroids were introduced
in the 1980s [5,6]. In the search for new active ingredients
it is essential that any biological screen of chemical
toxicity is representative and does not deviate from levels
of exposure experienced by vectors under natural (i.e.,
household) conditions, otherwise potential new classes of
toxin might be easily overlooked. Current WHO guidelines
for identifying new insecticides and measuring toxic activity
against malaria vectors are based on historic precedents
established for neurotoxins, such as pyrethroids, organo-
chlorines, carbamates, and organophosphates [7,8]. The
specific guidelines for insecticide-treated and long-lasting
nets are firmly rooted on knowledge accumulated by the
WHO Pesticide Evaluation Scheme (WHOPES) during the
testing of fast-acting pyrethroid products [8]. The initial
screen and assessment of insecticide efficacy is done using
a WHO cone test in which mosquitoes are exposed to
treated material for just three minutes and mortality
recorded a day later [7]. This is adequate for most types of
pyrethroid and will distinguish highly active from less
toxic compounds [7]. However, this approach, using
such short exposure times, may not be suitable for
screening and identifying novel classes of insecticide if
new classes of toxin do not excito-repel or act as fast as
the pyrethroids.
Chlorfenapyr is an insecticide new to vector control
from the class known as pyrroles [9,10]. Pyrroles are
broad-spectrum insecticides, which show contact and
stomach toxicity [11,12]. They are pro-insecticides which
require initial activation by mixed function oxidases to
produce the active compound [10]. Unlike the pyrethroids
and all other classes of insecticide currently approved for
adult mosquito control, the pyrroles’ site of action is not
the insect nervous system. Instead, pyrroles act at the
cellular level and disrupt respiratory pathways and
proton gradients through the uncoupling of oxidative
phosphorylation in mitochondria [10]. Because of its
unique mode of action, chlorfenapyr shows no cross
resistance to mechanisms that confer resistance to
standard neurotoxic insecticides against the mosquitoes
Anopheles gambiae, Anopheles funestus and Culex
quinquefasciatus [13,14], bed bugs Cimex spp. [15,16],
or beet armyworm Spodoptera exigua [17]. When applied
to mosquito nets occupied by human volunteers in experi-
mental hut trials, chlorfenapyr induces relatively high rates
of mortality among host-seeking mosquitoes regardless oftheir pyrethroid resistance status [18,19]. Yet in some types
of laboratory bioassay, chlorfenapyr appears slow acting or
induces patterns or levels of mortality that are not typical
of neurotoxic insecticides and not predictive of mortality
induced by chlorfenapyr-treated nets in hut trials [11,18].
Since chlorfenapyr is both activated by and acts upon oxi-
dative/respiratory pathways, its toxicity may be especially
sensitive to temperature or to the physiological status of
the insect, which in the case of the anopheline mosquito is
more metabolically active by night than by day due to
the phase of their circadian rhythm [20,21]. A new,
long-lasting, insecticide-treated net based on chlorfe-
napyr is being developed commercially. As part of
the development process the properties and toxicity
of chlorfenapyr were explored using a range of bio-
assay systems under ambient and controlled condi-
tions in order to better understand the mode of
action of pyrroles and to develop assay systems more
appropriate for screening and evaluating non-neurotoxic
insecticides.
The need to modify bioassay techniques for evaluation
of novel classes of LLIN insecticides is recognised as a
possibility in the latest WHOPES LLIN guidelines [8]. In
the series of experiments presented, chlorfenapyr serves
as representative novel insecticide and pathfinder for
a more rational approach for the determination of
chemical toxicity and bioassay thresholds that are more
predictive of activity under field conditions.
Methods
Insecticide formulations
Bioassay testing were carried out in parallel at the
two Pan-African Malaria Vector Research Consortium
(PAMVERC) trial sites in Moshi, Tanzania, and Cotonou,
Benin, during the course of a project between BASF
and Innovative Vector Control Consortium (IVCC)
aimed at developing a novel type of LLIN. Compari-
son is made between chlorfenapyr and the pyrethroid
alphacypermethrin which serves as a positive control.
Polyester netting, 100-denier, was treated with chlor-
fenapyr suspension concentrate (SC) 214.5 g/l, (BASF,
Ludwigshafen, Germany) or alphacypermethrin SC
60 g/l (BASF, Ludwigshafen, Germany). Each batch of
chlorfenapyr insecticide-treated net (ITN) was tested
in Ludwigshafen, Germany using gas–liquid chromatog-
raphy to confirm that mean dosages were within 10% of
target. Chlorfenapyr ITN samples are described as “with”
or “without binder” depending on whether polymers
were added to the SC formulation to improve wash
resistance. While the dosages applied, and adjuvants
added differed during product development, all experi-
ments investigating the effects of external factors or
conditions were carefully controlled or adjusted for in the
statistical analysis.
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In the first series, the mosquito mortality generated in
Phase 2 experimental hut trials of treated nets was cali-
brated against mortality generated in Phase 1 bioassay tests
in an attempt to determine more realistic bioassay exposure
times. In the second series, the standard WHOPES bioassay
tests (cone bioassay, cylinder bioassay, tunnel test) and the
efficacy thresholds established for the pyrethroid class were
assessed for their suitability for pyrroles. In the third, mos-
quito circadian motor activity in bioassay chambers was
compared by day and by night. In the fourth, the response
to insecticide in cone bioassay was compared by day and by
night. In the fifth, the response to insecticide was compared
across a range of temperatures representative of highland
and lowland transmission.
Determining rational exposure times for contact bioassay
more predictive of response in field conditions
The primary objective was to determine whether
percentage mortality achieved using WHOPES standard
three-minute contact bioassay was a fitting predictor of
chlorfenapyr ITN field performance or whether exposure
time should be changed. This was demonstrated by
comparing mortality in bioassay with mortality of wild
free-flying Anopheles arabiensis in experimental hut trials
in Tanzania. The methodology and results of the trial
(mortality and blood-feeding inhibition) have been pub-
lished previously [14]. Hand-dipped mosquito nets treated
with chlorfenapyr 100 mg/sq m or alphacypermethrin
25 mg/sq m were tested in the experimental huts for four
weeks. All ITNs used in the trial were tested in wire-ball
frame bioassays two days before the trial started to
assess toxicity against F1 generation of wild-caught
An. arabiensis that were resistant to pyrethroids [22,23].
Testing methodology was based on WHO protocol [7]
with the standard three-minute exposure compared
against a prolonged 30-minute exposure. Mortality was
recorded after 24, 48 and 72 hours to assess any delayed
mortality which is consistent with the mode of action of
chlorfenapyr [11]. Cotton pads soaked with 10% glucose
were provided throughout (and for all subsequent tests
unless stated otherwise).
Efficacy of chlorfenapyr compared to alphacypermethrin
in standard contact bioassay and tunnel tests
The standard WHOPES bioassay tests (cone bioassay,
cylinder bioassay, tunnel test) and the efficacy thresholds
established for pyrethroids were assessed for their
suitability for chlorfenapyr [8]. Day-time cone and cylinder
bioassays with the standard three-minute exposure were
compared with a prolonged 30-minute exposure. After
testing, mosquitoes were transferred to controlled tem-
perature incubators (LMS Models 240 and 600, Sevenoaks,
UK) and held at 27°C ± 0.5°C. Tunnel tests were conductedaccording to WHOPES protocol using the same netting
samples and test conditions [8]. The netting treat-
ments tested were chlorfenapyr 200 mg/sq m and
alphacypermethrin 25 mg/sq m. Testing was done in
Benin using insecticide susceptible An. gambiae Kisumu.
Mosquito circadian activity in bioassay chambers during
day and night phases
The objective was to observe mosquito behaviour, flight
and resting activity, in chambers of similar size to WHO
cones and cylinders and compare this during day-time
and night-time hours. The activity of mosquitoes was
monitored continuously using an acoustic actograph,
attuned to the wing-beat frequency of flying mosquitoes,
and which detects the spontaneous take-offs and landings
of individual mosquitoes without need for external inter-
ference or stimulation [20,21]. Twenty-four recording
chambers were constructed from standard 250-ml reagent
bottles that had their glass bases removed and with each
chamber separated from its microphone by a polyethylene
membrane fitted to the base of the reagent bottle. Individual
mosquitoes were housed in each chamber and provided
with a small tubule of sugar solution. The output from each
microphone fed into circuit that amplified the wing-beat
signals and operated the relay of an event-recorded pen.
Each mosquito was given a score of 1 for any minute that
contained flight activity, and thus a total of between 0 and
60 for each hour. These activity scores were averaged and
used to produce histograms of hourly activity against time.
Anopheles stephensi females were tested at five to six days
of age, and were inseminated, and sugar-fed rather than
blood-fed, consistent with host-seeking mosquitoes. Testing
was done using groups of 24 females over a period of four
to five days. In the first experiment, females were recorded
in a 12-hour light phase and 12-hour dark phase (LD 12:12)
synchronized with the insectary rearing regime. In the
second experiment females were recorded in constant
darkness (LD 0:24).
Insecticide bioassay efficacy related to the phase of the
mosquito circadian rhythm
The aim of this study was to determine whether exposure
to chlorfenapyr ITN in bioassay as done normally during
the day-time (12-hour light from 07:00–19:00) produced a
different mortality response than testing during the
night-time (12-hour dark from 19:00–07:00) phase when
anophelines are inherently more active metabolically and
behaviourally due to the phase of their circadian rhythm
[20,21]. Cylinder bioassays with 30-minute exposure were
conducted in Tanzania and Benin comparing testing in
the day-time between 10:00 and 16:00 and in the night-
time between 19:00 and 23:00. Mosquitoes were taken
from the same population cohort, and divided into one
group for night-time testing and one for day-time testing.
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from 07:00–19:00. Lights were kept off during dark phase
testing and kept on during day phase testing. Testing and
72-hour holding conditions were set at 27°C ± 0.5°C with
relative humidity (RH) 75% ± 15%. Three series of tests
were done, two in Tanzania and one in Benin. In the first
Tanzanian series, seven replicate netting samples were
treated in Germany with 200 mg/sq m chlorfenapyr
without binder. Testing was with An. gambiae Kisumu
(pyrethroid susceptible). In the second Tanzanian series,
five netting samples were treated in Germany with
200 mg/sq m chlorfenapyr plus binder. Testing was with
An. arabiensis F1. In the Benin series, the same five
netting samples treated in Germany with chlorfenapyr
200 mg/sq m plus binder were tested against pyrethroid
resistant An. gambiae VK-PER.
Effect of temperature on bioassay efficacy
The aim of this study was to determine whether the
response to chlorfenapyr was dependent on ambient
temperate during testing in day-time cylinder bioassays.
In the first series, the 1-hour acclimation (pre-exposure),
30-minute insecticide exposure and 72-hour post-
exposure holding was conducted at 22°C ± 1°C and
27°C ± 1°C using thermostatically controlled insectary
convection heaters and air conditioners. Anopheles
gambiae Kisumu (pyrethroid susceptible) was exposed
for 30 minutes to seven replicate netting samples of
200 mg/sq m chlorfenapyr without binder and mortality
recorded at 24-hour intervals up to 72 hours.
In the second series, cylinder tests were conducted at
2°C intervals between 21-29°C. After exposure at the
required temperature mosquitoes were transferred to
incubators set to the same testing temperature ±0.5°C
and 75% ± 20% RH for 72 hours holding. Temperature and
humidity were monitored using calibrated data loggers
(Gemini tinytag TV-4500, West Sussex, UK). Netting treat-
ments were with chlorfenapyr and alphacypermethrin.
Testing at different temperatures had to be done sequen-
tially rather than in parallel due to the limited number of
incubators available.
Analysis
Timing of bioassay in relation to mosquito circadian
rhythm
Mixed effect logistic regression models were used to
model mortality separately in each species or strain of
mosquito (An. gambiae Kisumu, An. arabiensis F1 and
An. gambiae VKPER) using STATA 10 software (STATA
Corp, College Station, USA). All statistical modelling
was performed on the log odds scale at the individual
mosquito level with a random effect specified to account
for similarities in mosquitoes tested at the same time
point, and for potential behavioural clustering within thesame test batch. The main predictor of interest was time
of testing (night vs day). Statistical models additionally
adjusted for insecticide, washing status, treatment
technique, drying temperature, and interactions between
each of these covariates and time of testing. The initial
model for each species was simplified by removing each
interaction term in turn via a process of manual
backwards elimination until only simple covariates
and statistically significant (p = 0.05) interactions with
time of day remained.
Effect of temperature on bioassay efficacy
Mixed effect logistic regression models were used as above.
The main predictor of interest was testing temperature.
For the 22°C versus 27°C comparison, statistical models
additionally adjusted for country where testing was done
(Benin or Tanzania) and treatment preparation. For
the 21-29°C testing range the same modelling was
performed but adjusted for insecticide (chlorfenapyr
or alphacypermethrin).
Ethical approval
Ethical approval was granted from the Tanzania National
Institute of Medical Research (NIMR/HQ/R.8c/Vol.I/24)
and London School of Hygiene & Tropical Medicine
Ethics Committee (Application no. 5162).
Results
Determining rational exposure times for contact bioassay
predictive of exposure to ITN under field conditions
Three-minute ball bioassay with 100 mg/sq m chlorfenapyr-
treated netting resulted in mortality of only 5% against F1
wild An. arabiensis, compared to 48% in experimental hut
trials of chlorfenapyr-treated nets against wild, free-flying
An. arabiensis (Figure 1). Clearly, three minutes exposure in
bioassay failed to predict performance against host-seeking
mosquitoes in huts. Prolonged exposure of 30 minutes
resulted in 58% mortality, closer to the mortality of
free-flying mosquitoes. Mortality of pyrethroid-resistant
F1 An. arabiensis [22,23] was also low for the alphacyper-
methrin netting in three-minute ball bioassay (1%) but the
alphacypermethrin-treated nets were effective in experi-
mental hut trials and killed 50%. Prolonged exposure of
An. arabiensis to alphacypermethrin netting in bioassay
(30 minutes) killed 88%.
Efficacy of chlorfenapyr compared to alphacypermethrin
in standard contact bioassay and tunnel tests
Under laboratory conditions a standard three-minute
cone bioassay on chlorfenapyr ITN 200 mg/sq m pro-
duced <5% mortality, while three-minute exposure to the
same chlorfenapyr netting in cylinder tests killed 30%.
More prolonged, 30-minute exposure in cylinder tests
produced 37% mortality. When tested in overnight tunnel
Figure 1 Comparison of experimental hut mortality of free
flying wild Anopheles arabiensis mosquitoes in the presence of
occupied ITNs and ball bioassay mortality after three and
30 minutes exposure to the same ITNs (see [8]).
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Adopting the WHO success threshold of 80% mortality in
cone or cylinder bioassay, chlorfenapyr failed to meet this
criterion with the standard three-minute exposure. Not
even 30 minutes exposure was sufficient to reach 80%
mortality. But chlorfenapyr did reach the 80% thresh-
old using the tunnel test. By contrast, the 25 mg/sq m
alphacypermethrin netting produced 100% mortality of
susceptible An. gambiae Kisumu in cone and cylinder
tests with three-minute exposure. Alphacypermethrin
therefore met the WHO success threshold of 80%
within the standard three-minute exposure and there-
fore did not need to undergo tunnel testing to achieve
this criterion.Figure 2 Comparison of bioassay response in Anopheles gambiae Kisu
standard WHO bioassay techniques: day-time cone and cylinder bioaMosquito circadian behaviour in bioassay chambers
during day and night
While An. gambiae responded to the toxic action of
pyrethroid exposure by day and night, response to
chlorfenapyr exposure was more evident in the night-
time assay (tunnel test) than in the day-time assays
(cone and cylinder). To explore this further the rest-
ing and flight activity of mosquitoes in chambers of
similar size to cones was examined using an actograph to
record spontaneous flight activity. In the LD 12:12 regime,
sugar-fed inseminated females showed no activity during
the 12-hour light phase but during the dark phase there
was an activity peak shortly after light off, followed by
short bursts of intermittent activity throughout the
12 hours of darkness and a small activity peak at ‘dawn’ as
the dimmer switched from darkness to light (Figure 3).
When, in the next experiment, the LD 12:12 regime was
changed to constant darkness (DD 12:12), a peak of flight
activity occurred regularly at 24-hour intervals during the
period which coincided with the former dark phase
but not the former light phase (Figure 3). Thus the
activity observed in the dark phase of LD 12:12 was
not a response to the switch from light to dark but the
expression of a free-running circadian activity rhythm
with a 24-hour periodicity that was being expressed
during the dark phase of LD 12:12 cycles.
Insecticide bioassay efficacy in relation to the phase of
the mosquito circadian rhythm
During the first series in Tanzania, mean mortality in-
duced by chlorfenapyr 200 mg/sq m samples tested at
night was 92% after 24 hours and 100% after 72 hours
(Table 1). The same samples tested during the day
induced far lower levels of mortality, with a mean ofmu to chlorfenapyr and alphacypermethrin-treated nets using
ssays and night-time tunnel tests.
Figure 3 Circadian flight activity of inseminated non blood-fed Anopheles stephensi in an acoustic actograph under a 12:12 hour
light/dark regime (top) and on transfer from a light/dark 12:12 hour to a constant darkness regime (bottom). Dark bars on x-axis refer
to periods of darkness, white bars to periods of light. Hourly flight activity is a score (out of 60) indicating the number of minutes per hour during
which mosquitoes undertook flight.
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CI: 3.1-23.7, P <0.001, comparing night and day
response). After 72 hours the difference in mortality
between day-time and night-time exposure was less
pronounced as mortality converged towards 100%.
Whereas all samples tested at night scored 100% only
one of the seven samples tested in the day-time
reached 100%.
In the second series in Tanzania, chlorfenapyr 200 mg/
sq m induced significantly greater mortality of An.
arabiensis F1 when tested during the night than during the
day (odds ratio 10.5, 95% CI 4.3-25.7, P <0.001) (Table 1).
Mean 72-hour mortality was 26% (95% CI: 21–31)
when tested during the day compared to 63% (95%
CI: 57–68) at night. In the third series, tested in Benin,
chlorfenapyr 200 mg/sq m produced a similar trend againstthe pyrethroid-resistant An. gambiae VKPER, scoring
higher mortality when tested at night (mean 58%,
95% CI: 51–66) than when tested at day (mean 39%, 95%
CI: 32–47) (odds ratio 2.4, 95% CI 1.5-4.0, P = 0.001)
(Table 1).
Effect of temperature on bioassay efficacy
In the first series the factor of interest on chlorfenapyr
activity was temperature at 22°C or 27°C during testing
and holding. The seven samples (A-G) treated with
chlorfenapyr 200 mg/sq m killed between 12 and 45%
when tested at 22°C and killed 82-100% when tested
at 27°C (odds ratio 41, 95% CI: 27–63, P <0.001) (Figure 4).
The country of testing had no significant effect (P = 0.154).
In the second series, the bioassay mortality was
compared at testing intervals of 2°C in a range of 21-29°C.
Table 1 Comparison of day-time and night-time testing of chlorfenapyr 200 mg/sq m insecticide-treated net using
30-minute exposure in cylinder bioassays
24 h Mortality 72 h Mortality
Day Night Odds ratio Day Night Odds ratio
Tanzania, An. gambiae Kisumu
Chlorfenapyr 200 mg/sq m (95% CI) 65 (56–72) 92 (86–96) 8.5 (3.1-23.7) P < 0.001 90 (84–94) 100 †
Tanzania, An. arabiensis F1
Chlorfenapyr 200 mg/sq m (95% CI) 8 (5–12) 41 (35–47) 14.1 (5.9-33.6) P < 0.001 26 (21–31) 63 (57–68) 10.5 (4.3-25.7) P < 0.001
Benin, An. gambiae VKPER
Chlorfenapyr 200 mg/sq m (95% CI) 9 (6–15) 10 (6–16) 1.0 (0.5-2.1) P < 0.974 39 (32–47) 58 (51–66) 2.4 (1.5-4.0) P < 0.001
Notes: † indicates that statistical models could not produce an odds ratio estimate.
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positive temperature coefficient, with mortality increasing
with every increment of 2°C. Focusing on the WHOPES
recommended testing range of 27°C ± 2°C, there was an
odds ratio of 10.4 (95% CI = 5.5-19.6, P <0.001) associated
with the 4°C increase in temperature from 25-29°C
for chlorfenapyr ITN compared with only 1.7 for
alphacypermethrin (95% CI = 0.9-3.1, P = 0.075). The
alphacypermethrin net of 100 mg/sq m killed 100% of
pyrethroid-susceptible An. gambiae Kisumu at all
temperatures. To improve the prospect of discriminating
between temperature intervals, lower dosages of alphacy-
permethrin at 0.5 and 1 mg/sq m were tested. While this
had the desired effect of killing less than 100%, the pro-
portions killed across the 21-29°C range were similar at all
intervals (Figure 5). Predicted mean mortality projections
for chlorfenapyr showed strong evidence (odds ratio = 1.8;
95% CI 1.5-2.1, P <0.001) of a mortality-temperature
response for every 1°C increase in temperature. There wasFigure 4 Effect of temperature (22°C versus 27°C) on % mortality (72
chlorfenapyr ITN in Tanzania and Benin after day-time exposure of 30little evidence of a mortality gradient with temperature
for alphacypermethrin (odds ratio = 1.1; 95% CI 1.0-1.3,
P = 0.075) (Figure 6).
Discussion
Pyrethroid resistance has spread rapidly as a result of
scaling up LLIN and indoor residual spraying (IRS) and is
now present at high frequency in many areas of sub-
Saharan Africa [2]. It is clear that new insecticides for LLIN
are urgently needed if momentum towards malaria elimin-
ation is to continue [1]. Pyrethroid insecticides have ideal
properties for use on mosquito nets. They are highly toxic
and fast acting against mosquitoes, provide repellency
and personal protection [24,25], are safe for users
(low mammalian toxicity) [26], and can be readily made
into wash-resistant LLINs [4]. New insecticides are unlikely
to have the same properties of rapid knock-down and mor-
tality but can still be effective in transmission control if
mosquitoes contact treated netting for a sufficient duration.hours) in bioassays with Anopheles gambiae Kisumu tested on
minutes in cylinder bioassays.
Figure 5 Percentage mortality of Anopheles gambiae Kisumu (72 hours) following 30-minute cylinder bioassay of chlorfenapyr and
alphacypermethrin ITN samples at 2°C intervals between 21and 29°C.
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spend in contact with untreated or treated mosquito
nets. Hossain and Curtis used artificial releases to
demonstrate that susceptible An. gambiae spend up
to 21 minutes in contact with an untreated net but
only three minutes on a permethrin-treated net [27].
Three minutes is the standard WHO specified cone
bioassay exposure time for ITNs regardless of the
insecticide evaluated. This is a suitable duration of
exposure for neurotoxic, excito-repellent, pyrethroid
insecticides, where a mosquito either picks up a lethal
dose or is repelled within a short time of contacting
the ITN. Other classes of insecticide may require longer
exposures to produce high levels of mortality. TheFigure 6 Predicted mortality of Anopheles gambiae Kisumu by
treatment between 21 and 29°C.time spent in contact with the net is influenced by
the contact-irritancy of the insecticide [28]. Once
mosquitoes become resistant to pyrethroids they show
less irritability and spend longer in contact with the
net [28]. Calibration of exposure time and mortality in
bioassay with efficacy of alphacypermethrin-treated nets
in experimental huts indicates that pyrethroid-resistant
An. arabiensis spends much longer than three minutes
but less than 30 minutes in contact with the treated net.
The calibration of chlorfenapyr bioassay results with
experimental hut efficacy justifies longer exposure
times for non-repellent insecticides in WHO cone
bioassay tests.
WHOPES sets the international standards for testing
LLIN [8]. WHOPES guidelines state that “The efficacy
of treated nets may be underestimated if judged based
on the outcome of standard cone bioassays” [8]. If a
candidate LLIN fails to achieve the threshold level of
mortality in a three-minute cone test (80% mortality), as
sometimes happens with more repellent pyrethroids, its
efficacy is evaluated in the overnight tunnel test [8]. In
the laboratory comparison of alphacypermethrin and
chlorfenapyr, the pyrethroid easily met the threshold
mortality in the cone test and did not require to go
forward to tunnel testing. Chlorfenapyr produces little
or no irritancy at application rates <500 mg/sq m
[11,29], and yet in the cone and cylinder tests not
only did chlorfenapyr fail to achieve the threshold
80% mortality with three-minute exposure, it could only
achieve half this level of mortality with 30-minute exposure.
Only the laboratory tunnel test achieved a level of mortality
that met the 80% threshold [8].
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criteria so abjectly can produce excellent results in
overnight tunnel tests and experimental huts? The answer
resides in the unique mode of action. Unlike neurotoxic
pyrethroids, chlorfenapyr acts by disrupting metabolic
respiratory pathways (oxidative phosphorylation) in the
mitochondria of cells [10]. It is also a pro-insecticide
requiring conversion to the active compound by the
action of cellular mixed-function oxidases [10]. The
expression in An. gambiae of some cytochrome P450s
involved in oxidative metabolism are under circadian
control and more strongly expressed at night [30].
Anopheline flight and host-seeking activity is a high-energy,
high-respiratory behaviour which is also under circadian
control and occurring only at night [20,21]. A model for
chlorfenapyr is that the metabolic conversion to the active
compound, CL 303268, is more strongly expressed at night,
at the time of day when cellular respiration is also at its
zenith due to the circadian flight activity rhythm and when
the uncoupling of respiratory pathways would be at their
most disruptive to the mosquito [20,21]. Such a model
would explain the high levels of mortality in experimental
huts and night-time bioassays against active mosquitoes
(tunnel test and night-conducted cylinder test) and also
account for the low level mortality observed in day-time
bioassays.
The activation of chlorfenapyr and its toxic action
of disrupting cellular respiration, being metabolic pro-
cesses, are both presumed to be temperature dependent.
This would explain the stronger correlation between
temperature and day-time bioassay mortality with
chlorfenapyr than observed with the pyrethroid alpha-
cypermethrin. Crucial to the toxicity of chlorfenapyr
is the circadian rhythm of the mosquito. During the night,
when mosquitoes are at their most behaviourally active
due to their circadian phase, exposure to chlorfenapyr
induces a high level of mortality independent of ambient
temperature. This concurs with the high mortality (53.5%)
observed during hut trials [18] in equatorial Benin
(altitude 9 m) where average temperature was 27°C
and the similarly high mortality (48%) during trials
[19,22] in upland areas of Moshi, Tanzania (altitude
760 m) where average temperature was only 23°C and
the average night-time temperature of 17°C was 8°C
lower than the 25°C of Benin [31]. Presumably the
circadian phase, or the expression of chlorfenapyr
toxicity on cellular respiration during that phase, has
the capacity to offset or over-ride any effect of reduced
ambient temperature. Because wild, host-seeking Anopheles
are more metabolically active than mosquitoes in day-time
bioassay, this can mask the effect of low ambient
temperature in highland areas, as indicated in the published
trials with chlorfenapyr ITNs and IRS in cooler Moshi,
Tanzania [18,19,22]. In short, chlorfenapyr is effective bothin lowland tropical locations where night temperatures are
particularly hot and in highland areas where temperatures
are cooler.
Circadian rhythm and ambient temperature both affect
metabolic status. Most types of laboratory bioassays to
determine the efficacy and wash-resistance of LLIN are
conducted during day time [8].The model to explain the
improved performance of chlorfenapyr ITN when tested
at night can also explain the improved day-time mortality
when a mosquito is more metabolically active due to
raised ambient temperature. WHOPES guidelines for
evaluation of LLINs state that contact bioassays should be
conducted at 27°C ± 2°C (i.e., 25-29°C) [8]. Considering
the high odds (10.4) for An. gambiae mortality with
chlorfenapyr ITN at 29°C compared to 25°C, this is
likely to lead to significant variation in test results between
laboratories unless strict temperature control, such as the
use of incubators and data loggers are deployed as quality
assured best practice. Bioassay testing temperature is less
sensitive for pyrethroids. In this study there was no signifi-
cant evidence of a temperature-mortality gradient for
alphacypermethrin. Generally for pyrethroids a negative
temperature coefficient with mortality has been recorded
for the majority of insect species evaluated, over a larger
temperature range [32-35], and appears to be due to greater
nerve sensitivity [32].
Because experimental hut trials simulate domestic
conditions, they provide the definitive test of LLIN
efficacy [8]. Cone or cylinder bioassays conducted at night,
when the phase of the circadian rhythm means that that
the mosquito is both behaviourally and metabolically
active, are likely to be more predictive of efficacy in huts.
Such testing is inconvenient to perform unless mosquito
rearing and testing are carried out under insectary reverse
photophase. The overnight tunnel test is likely to be the
more accurate predictor of field performance as the
mosquito is host seeking during the active phase of the
circadian rhythm, and contacts netting in a more realistic
way when attempting to reach the animal host. Despite
being technically more demanding, overnight tunnel
tests should always be conducted when screening for
insecticidal activity from novel classes to ensure that
insecticides which may be potent when tested against
wild host-seeking mosquitoes are not overlooked based on
an artificial, fixed exposure bioassay.
WHOPES guidelines have been developed for the
evaluation of pyrethroid nets [7,8]. New insecticides for
LLIN, such as chlorfenapyr, will not have the same
properties as pyrethroids; ultimately, high mortality
and low blood feeding in field trials against wild malaria
vectors are the most important measures of success.
These studies have highlighted the need to adapt
laboratory-testing protocols for the evaluation of novel,
non-neurotoxic insecticides. If current WHOPES guidelines
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cides that are highly effective against wild mosquitoes, such
as chlorfenapyr, would be overlooked at the screening stage
of evaluation through bioassay and never progress to field
evaluation. The current emphasis on Phase 1 test criteria
and thresholds developed and tailored for pyrethroids will
not serve for the new classes of insecticide. Revision of the
WHOPES LLIN evaluation guidelines, putting emphasis
on tunnel tests which simulate or allow expression
of night-phase, host-seeking behaviour on the net, are
urgently required.
Conclusions
The pyrrole insecticide chlorfenapyr shows great promise
as an alternative to pyrethroids for use on nets. Its mode of
action and characteristics in laboratory bioassay differ from
those of neurotoxic insecticides such as pyrethroids. Stand-
ard WHO bioassay test criteria (such as the 80% mortality
threshold) may not be achievable and such tests may fail to
predict the performance of novel active ingredients in field
trials. The three-minute exposure cone test should be aban-
doned as screening bioassay for novel insecticides because
the exposure time is too short. Exposure time for novel
active ingredients should be established by calibration of
mortality of free-flying mosquitoes in experimental huts
with bioassay mortality across a range of exposure times.
For non-neurotoxic insecticides, which act or disrupt meta-
bolic pathways, the bioassay should take into account the
mosquito’s circadian activity rhythm and metabolic status.
The WHO tunnel test on night-active mosquitoes is the
most relevant and predictive bioassay for identifying or
establishing the toxicity of new active ingredients on nets.
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